We alternately evaluated STAT3 expression in the nucleus and found that the patients with high STAT3 expression in the tumor nucleus were at significantly higher risk of both disease progression (p = 0.003) and cancer-specific mortality than the other patients (p = 0.034, Fig 3). The gene discussed is STAT3; the disease is cancer.